Showing results (801-810 of 5,007) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|December 22, 2009
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1)Gabriella Macchia, Gabriella Ferrandina, Francesco Legge, et al.American Journal of Clinical Oncology|December 22, 2009
Ductal carcinoma in situ: size and resection volume predict margin statusLaleh G Melstrom, Kurt A Melstrom, Edward C Wang, et al.American Journal of Clinical Oncology|January 7, 2010
A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by ageBreanne E Terakedis, Peter J Rossi, Stanley L Liauw, et al.American Journal of Clinical Oncology|January 7, 2010
Identifying subsets of metastatic breast cancer patients likely to benefit from treatment with the epothilone B analog ixabepiloneSeema Harichand-Herdt, Ruth M O'reganAmerican Journal of Clinical Oncology|December 17, 2009
Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapyJesse N Aronowitz, Jeff M Michalski, Gregory S Merrick, et al.American Journal of Clinical Oncology|April 1, 1994
Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancerK A Margolin, S Green, K Osborne, et al.American Journal of Clinical Oncology|April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study GroupT Conroy, P Cappelaere, M Fabbro, et al.American Journal of Clinical Oncology|November 26, 2009
Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group StudyAlan H Bryce, Bassam Mattar, Shauna L Hillman, et al.American Journal of Clinical Oncology|April 30, 2019
Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014James B Yu, Craig E Pollack, Jeph Herrin, et al.American Journal of Clinical Oncology|October 1, 1986
Nuclear DNA content in mammary carcinomas in women aged 35 or youngerA von Rosen, A Fallenius, B Sundelin, et al.Pageof 501